Clinical Trials Browser

INDUSTRY × Myeloid Malignancy × venetoclax × Clear all

NCT04214860 2025-03-17

APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies

Phase 1 Completed

51 enrolled 9 charts

Myeloid Malignancy